MMGZ01, a novel human DLL4-specific monoclonal antibody, was found to inhibit tumor growth through various mechanisms, namely inhibition of tumor cell proliferation, promotion of tumor cell apoptosis and reduction in the cancer stem-like cell population, leading to the reversal of EMT [105]. Here, DLL4 is linked to neoplasm.